Product Images Aripiprazole

This is a description of Aripiprazole Tablets, USP, batch no. MACLEODY, manufactured by Macleods Pharma USA, Inc. Each tablet contains 10mg of Aripiprazole, USP, and it should be stored at a temperature between 20° to 25°C (68° to 77°F), with excursions permitted to 15° to 30°C (59° to 86°F). The package contains 100 tablets (10 x 10 Unit dose) and is not child-resistant. Pharmacists are advised to dispense the accompanying medication guide to each patient. The text does not contain any further information.*

This is a medication label for Aripiprazole, with each tablet containing 10 mg of the active ingredient. Dosage and prescription information is available and the drug should be stored at temperatures between 20°C to 25°C. The medicine is manufactured by Macleods Pharma USA.*

Aripiprazole Tablets, USP is a medication that comes in 100 tablets (10 x 10 unit dose) and is manufactured by Macleods Pharmaceuticals Ltd. for Macleods Pharma USA, Inc. It contains Aripiprazole, 15 mg and should be stored at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Each patient should be dispensed the accompanying Medication Guide. Dosage and administration should be followed as outlined in Prescribing Information. The unit-dose package is not child-resistant.*

This is a description for a medication named Aripiprazole manufactured by Macleods Pharma USA, Inc. Each tablet contains 15mg of Aripiprazole USP. The tablets are 40X15 mm and are to be stored at 20° to 25°C. The medication information for dosage and administration can be found in the accompanying medication guide. It is available in a package of 30 tablets and its code number is HP/152/07.*

This is a description of a medication packaging of Aripiprazole Tablets, USP. It contains 100 tablets (10 x 10 unit dose), with a batch number of 12612 and an expiration date. The tablets are manufactured by Macleods Pharmaceuticals Ltd. and distributed by Macleods Pharma USA, Inc. There are instructions for dispensing a medication guide to each patient. The package is not child-resistant. More information about dosage and administration can be found in the prescribing information.*

Aripiprazole Tablets, USP are available in a bottle of 30 tablets. Each tablet contains Aripiprazole, USP. The usual dosage should be seen in the prescribing information for Dosage and Administration. These tablets should be stored in a controlled room temperature, between 20° and 25°C or 68° and 77°F, and excursions permitted to 15° to 30°C or 59° to 86°F. Dispense the accompanying Medication Guide provided to each patient by the pharmacist. Manufactured by Macleods Pharmaceuticals Ltd for Macleods Pharma USA, Inc. The Code No. is HP/152/07.*

Macleods Pharma USA produces Aripiprazole Tablets, USP 2mg, containing 100 tablets in a package. The medication guide should be dispensed to each patient along with the batch number, expiration date, and manufacturing information. It is advised to store the tablets at room temperature, and the package is not made child-resistant. Dosage and administration details should be referred to the prescribing information.*

This is medication information for Aripiprazole tablets, USP prescribed in the dosage mentioned in the prescribing information. The pharmacist is instructed to dispense the medication guide to patients. The tablets contain Aripiprazole USP of 2mg strength and are to be stored at 20-25°C with permitted excursions. The medication is manufactured for Macleods Pharma USA, Inc. It comes in a pack of 30 tablets and is manufactured in Baddi, Himachal Pradesh, INDIA.*

Aripiprazole Tablets, USP 30 mg is a prescription drug manufactured and distributed by Macleods Pharma USA, Inc. It is batched and each unit-dose package contains 100 tablets (10x10). The tablets are not child-resistant and the pharmacist is advised to dispense the accompanying medication guide to every patient. The product should be stored at a room temperature not exceeding 25°C. Dosage and administration information can be found on the prescribing information enclosed.*

Pharma USA has produced Aripiprazole Tablets with strength 30mg. Each tablet consists of Aripiprazole, USP 30 mg. The medication guide should be dispensed to each patient by the pharmacist. It is advisable to store the tablets at 20° to 25°C. Macleods Pharmaceuticals Ltd has manufactured the tablets for Macleods Pharma USA, Inc., Plainsboro, NJ, USA. The USP Controlled Room Temperature governs excursions from 15° to 30°C (59° to 86°F). For information on Dosage and Administration, consult Prescribing Information.*

Aripiprazole Tablets, USP packaged as ReOnly 100 tablets with Batch No. MACLEODY were manufactured by Macleods Pharmaceuticals Ltd. for Macleods Pharma USA Inc. The tablets contain Aipiprazole, USP 5mg and are to be stored at room temperature (20° to 25°C) with permitted excursions to 15° to 30°C. This package is not child-resistant. The prescribing information must be verified for dosage and administration. Pharmacist instructions recommend the inclusion of a medication guide for each patient. No additional information on the usage and side-effects of the medication can be found in the available text.*

This is a medication called Aripiprazole, which is available in tablet form. Each tablet has 5mg of Aripiprazole, USP, and the usual dosage should be followed per the prescribing information. It should be stored at a controlled room temperature between 20°C to 25°C (68°F to 77°F), with some excursions permitted to 15°C to 30°C (59°F to 86°F). This medication is manufactured by Macleods Pharma USA, Inc. and distributed in a bottle containing 30 tablets. The NDC code for this medication is 33342-123-07. The package comes with a medication guide which should be given to each patient by the pharmacist.*

The text describes the effect of different drugs on the pharmacokinetics of Avipiprazole. The drugs are categorized based on their ability to inhibit or induce certain CYP enzymes in the liver. The text presents fold changes and confidence intervals for each drug. The drugs include Ketoconazole, anidne, Corvamazegne auc, famodine, valproate, and lrszepam.*

Effect of different drugs on the metabolism of a reference drug is being discussed here. CYP3A inhibitors ketoconazole and CYP206 inhibitors iricine suc are known to increase the concentration of the reference drug. CYP3AM inducer cobomazepine, on the other hand, decreases the concentration of the reference drug. The impact of other drugs, such as famotaine, vaproste, lorazepam, and Avipiprazole, on the reference drug's metabolism is not clear from the available text.*